|retinopathy of prematurity (ROP)
|Our results suggest that plasma miRNA levels may alter in ROP and, some miRNAs might have an effect in the physiopathology of this disease. These molecules may have an important therapeutic role in patients who are unresponsive to anti-vascular endothelial growth factor therapy.
|Evaluation of the plasma microRNA levels in stage 3 premature retinopathy with plus disease: preliminary study.
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.